Sandur Manganese subsidiary leases 6.2 acres for medical devices unit
- Royal Sandur MedTech leased 6.2 acres at AMTZ Visakhapatnam on October 19, 2026
- Lease tenure is 33 years with freehold conversion option after 10 years
- Move marks Sandur Manganese's entry into medical devices and consumables sector
- Subsidiary will utilize AMTZ's common manufacturing and scientific facilities
*this image is generated using AI for illustrative purposes only.
Sandur Manganese & Iron Ores has expanded its diversification strategy into the medical devices sector. Its wholly owned subsidiary, Royal Sandur MedTech Private Limited, has leased 6.2 acres of land at the Andhra Pradesh MedTech Zone (AMTZ) in Visakhapatnam to establish a manufacturing facility.
The lease deed was executed on October 19, 2026, between Royal Sandur MedTech and Andhra Pradesh MedTech Zone Limited, a Government of Andhra Pradesh undertaking. The agreement grants a 33-year lease tenure with an exclusive option to convert leasehold rights into freehold ownership after 10 years from the date of business commissioning. The site includes developed infrastructure such as road, power, water, and effluent systems provided by AMTZ.
Strategic Diversification
This move marks a concrete step for Sandur Manganese, traditionally known for mining and metals, into healthcare manufacturing. Bahirji A. Ghorpade, Managing Director of Sandur Manganese & Iron Ores, stated that the company intends to build new engines of growth alongside its core businesses. He highlighted that AMTZ offers common manufacturing and scientific facilities, allowing new entrants to build capabilities in a capital-efficient manner.
Dr. Jitendra Sharma, Managing Director and Founder CEO of AMTZ, welcomed the investment, noting it reflects growing confidence in India's medical technology manufacturing capabilities. The collaboration aims to accelerate India's journey toward becoming a global hub for healthcare innovation.
What the Numbers Show
The transaction highlights a strategic shift in capital allocation for Sandur Manganese. While the company remains anchored in Mining, Ferroalloys, Coke, Energy, and Specialty Steel through its subsidiary Royal Sandur Metals, the acquisition of a long-term industrial lease signals a commitment to high-value-added manufacturing. The 6.2-acre footprint (approximately 25,090 square metres) is modest compared to its existing mining operations but represents a targeted entry into a regulated, high-growth sector. The option to convert to freehold after a decade provides long-term asset security, mitigating risks associated with pure leasehold models in industrial projects.
Key Lease Terms
| Parameter | Details |
|---|---|
| Lessee | Royal Sandur MedTech Private Limited |
| Lessor | Andhra Pradesh MedTech Zone Limited |
| Location | Visakhapatnam, Andhra Pradesh |
| Area | 6.2 acres (approx. 25,090 sq m) |
| Tenure | 33 years |
| Conversion Option | Freehold after 10 years of commissioning |
| Infrastructure | Road, power, water, effluent provided |
Further details regarding capital expenditure plans and specific project timelines are expected to be announced in due course. The company also secured office space at the World Trade Center AMTZ to support initial project development.
Historical Stock Returns for Sandur Manganese & Iron Ores
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.54% | -8.73% | -11.34% | -23.45% | -28.03% | +83.03% |
What specific categories of medical devices will Royal Sandur MedTech prioritize in its initial manufacturing phase?
How does Sandur Manganese plan to address the regulatory and technical skill gaps required for entering the highly regulated healthcare sector?
What is the projected capital expenditure budget for the Visakhapatnam facility, and how will it impact the company's near-term cash flow?
15
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
